Drug Shortage Resolved

Article

Drug Shortage Resolved

Oxford Pharmaceutical's (Totowa, NJ) antidepressant drug “Marplan” (isocarboxazid, 10-mg dosage) has been removed from the US Food and Drug Administration’s list of drug shortages. Oxford resumed normal distribution of Marplan on May 27.

Marplan is a second-line treatment for depression offered as an option for patients who are unresponsive to other antidepressants such as selective serotonin reuptake inhibitors or traditional antidepressants such as amitriptyline.

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content